Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 16.72 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Momenta Pharmaceuticals Inc | MNTA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.11 | -0.65% | 16.72 | 16.94 | 15.94 | 16.72 | 16.83 | 17:59:41 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 14.70 | 17.07 | 2.37 | 13.88% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,401 | 1,053,602 | $ 16.61 | $ 17,503,581 | 928,732 | 9.51 - 18.39 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:30:31 | 2 | $ 15.89 | USD |
Momenta Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 1.66B | 99.02M | $ -176.06M | -2.25 | - | 94.84M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Momenta Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MNTA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 16.98 | 18.39 | 15.25 | 16.93 | 1,931,403 | -0.26 | -1.53% |
| 1 Month | 16.15 | 18.39 | 15.13 | 16.57 | 1,011,902 | 0.57 | 3.53% |
| 3 Months | 13.32 | 18.39 | 12.21 | 15.57 | 622,315 | 3.40 | 25.53% |
| 6 Months | 12.11 | 18.39 | 9.51 | 13.85 | 554,244 | 4.61 | 38.07% |
| 1 Year | 11.95 | 18.39 | 9.51 | 13.36 | 546,988 | 4.77 | 39.92% |
| 3 Years | 14.50 | 32.20 | 9.51 | 15.99 | 660,147 | 2.22 | 15.31% |
| 5 Years | 12.19 | 32.20 | 7.86 | 15.73 | 652,789 | 4.53 | 37.16% |
Momenta Pharmaceuticals Description
| Momenta is a biotechnology company focused on the characterization and development of innovative drugs in autoimmune diseases. Its legacy business includes complex generic versions of MS drug Copaxone and anticoagulant Lovenox, and it receives royalties for these products through a partnership with Novartis. While biosimilar versions of Humira and Eylea are in the pipeline, Momenta terminated future development in generics/biosimilars in 2018. Several innovative drugs, including M281, M254, and M230, are in development to treat rare autoimmune diseases. |
